Comparative Pharmacology
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL 137 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIALYTE LM DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL 137 W DEXTROSE 1 5 IN PLASTIC CONTAINER.
DIALYTE LM/ DEXTROSE 1.5% IN PLASTIC CONTAINER vs DIANEAL 137 W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Peritoneal dialysis solution with dextrose as osmotic agent; dextrose creates osmotic gradient across peritoneal membrane to remove excess fluid and uremic toxins.
DIANEAL 137 with 1.5% dextrose is a peritoneal dialysis solution that removes waste products and excess fluid from the blood by creating a concentration gradient across the peritoneal membrane via diffusion and ultrafiltration. Dextrose acts as an osmotic agent to drive fluid removal.
Intraperitoneal administration via automated peritoneal dialysis (APD) or continuous ambulatory peritoneal dialysis (CAPD); typical adult dose is 2-3 liters per exchange, 4-5 exchanges per day (CAPD) or 8-12 liters total volume per night (APD).
Intraperitoneal administration: 2 liters per exchange, typically 4 exchanges per day for continuous ambulatory peritoneal dialysis (CAPD).
None Documented
None Documented
Not applicable: Dextrose absorbed from peritoneal dialysate has a half-life similar to IV glucose (approx. 1-2 hours), but as a dialysis solution, the concept of terminal elimination half-life is not defined for the non-absorbed components. Clinical context: continuous intraperitoneal administration.
Not applicable for dextrose as it is an endogenous substance. Exogenous dextrose in peritoneal dialysis is rapidly metabolized; plasma glucose half-life is approximately 1-2 hours after absorption, but this varies with metabolic state.
Peritoneal dialysis fluid: DIALYTE components (electrolytes, dextrose) are not systemically absorbed in clinically significant amounts; dextrose is partially absorbed across the peritoneum and metabolized. Renal and biliary excretion are not relevant as this is a topical intraperitoneal solution. Elimination of absorbed dextrose follows glucose metabolism (oxidation, storage).
Dianeal 137 with 1.5% dextrose is a peritoneal dialysis solution. Dextrose is metabolized systemically; glucose is absorbed via peritoneal route and undergoes endogenous metabolism. Icodextrin (if applicable) is metabolized to maltose and excreted renally, but for this standard solution, elimination is primarily via metabolism to CO2 and water; less than 5% excreted unchanged in urine. No biliary or fecal elimination of intact dextrose.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution